Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Get Free Report)’s share price dropped 3% on Tuesday . The company traded as low as $0.70 and last traded at $0.71. Approximately 56,540 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 326,765 shares. The stock had previously closed at $0.73.
Sol-Gel Technologies Trading Down 3.0 %
The firm has a market capitalization of $19.78 million, a P/E ratio of -2.09 and a beta of 1.31. The company’s fifty day moving average is $0.84 and its 200-day moving average is $0.67.
About Sol-Gel Technologies
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.
Read More
- Five stocks we like better than Sol-Gel Technologies
- Conference Calls and Individual Investors
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Stock Market Sectors: What Are They and How Many Are There?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Most active stocks: Dollar volume vs share volume
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Sol-Gel Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sol-Gel Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
